MBIO:NASDAQ
Mustang Bio Inc
$0.43
0.00%
(0.00) 1D
$0.45
arrow_upward
+0.91% (+0.00)todayPre-market
Closed: Nov 11, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Mkt. cap
3.26M
Avg. vol.
41.82K
Volume
2.00
52-wk high
$1.43
52-wk low
$0.35
EPS
-$0.46
Beta
2.20
Shares outstanding
6.74M
No. of employees
4
Mkt. cap
3.26M
Avg. vol.
41.82K
Volume
2.00
52-wk high
$1.43
52-wk low
$0.35
EPS
-$0.46
Beta
2.20
Shares outstanding
6.74M
No. of employees
4
News stories
From web sources and news partners
Benzinga
·
1 day ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitemustangbio.com